Tolemy Bio is a Cambridge and Barcelona-based biotech startup building the virtual-cell intelligence layer for modern biopharma. Founded in 2024 by Alex Ward and Caelan Anderson, the company’s platform, Orbit, combines experimental data, agentic AI and virtual-cell models to help advanced therapy and biologics teams make their cell biology more predictable, interpretable and controllable.
Tolemy Bio: Venture Capital Funding History
Tolemy Bio
Tolemy Bio
- Life Sciences
- Cambridge, United Kingdom
- £1.2m
- tolemy.bio
- Update Information
More venture news
- 26 Oct 2026
adsilicoadsilico unlocks a £10m Series A round led by PXN Ventures for virtual testing of implantable medical devices
Series ALife Sciences - 26 Oct 2026
imphatecimphatec raises a £1.5m seed round led by SynBioVen to develop customisable-dose implants for chronic conditions
SeedLife Sciences - 15 Oct 2026
OMass TherapeuticsOMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platform
Series CLife Sciences
